Home
Search
BIO Early-Stage Resources Hub

BIO Early-Stage Resources Hub

Access a range of exclusive resources, including cost-saving programs, educational webinars and stay up-to-date with the latest BIO Emerging Companies Section (ECS) events with our comprehensive resource center, designed to empower early-stage companies and help them thrive.

  • Show All
Results
  • Show All
PDF
Testimony: "The Impact of Consolidation and Monopoly Power on American Innovation" (12/15/2021)
FLIP
Testimony of BIO’s Chief Policy Officer before the Senate Subcommittee on Competition Policy, Antitrust, and Consumer Rights on consolidation and monopoly power.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
The State of Innovation in Antibacterial Therapeutics
FLIP
This report investigates recent investment into antibacterial innovation and the current clinical pipeline that will help bridge the gaps in the antibacterial armamentarium.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases
FLIP
This report focuses on vaccine innovation and success at the clinical stage, as well as the innovation of prophylactic antibodies in clinical trials.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
BIO Large Biopharma Therapeutic Focus Resource
FLIP
This resource provides guidance to assist early-stage companies in identifying potential large biopharma partners.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Chubb Cyber Index
FLIP
Contains graphs and charts on cyber threat trends. View data on assets affected, annual claims, and more by industry and revenue size.
DOWNLOAD PDF
VIEW PDF
FLIP
Apr 7, 2024
Emerging Therapeutic Company Investment and Deal Trends
GO TO SITE
FLIP
Apr 7, 2024
New BIO Industry Analysis trend data have been released for Emerging Therapeutic Company Investment, R&D-Stage Out-licensing, and Acquisitions.
GO TO SITE
FLIP
PDF
Grant Application Timeline
FLIP
A three-month schedule for completing an SBIR/STTR grant application including key activities to complete.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Statement for the Record: "American Ingenuity: Promoting Innovation Through the Tax Code"
FLIP
BIO letter to House Small Business Committee outlining 7 tax policy recommendations for supporting biotechs.
DOWNLOAD PDF
VIEW PDF
FLIP
FILE
The Enhancement and Standardization of Climate-Related Disclosures for Investors (6/17/2022)
FLIP
Comments on proposed rule to require information about a registrant’s climate-related risks that are reasonably likely to have a material impact on its business, results of operations, or financial condition.
DOWNLOAD FILE
FLIP